Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum

Journal of Rheumatology

Volumn 35, Issue 7, 2008, Pages 1464-

  Vassilopoulos, Dimitrios ^a   Stamoulis, Nikolaos ^a   Hadziyannis, Emilia ^a   Archimandritis, Athanasios J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ANTIBODY;

ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 47349126860     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AI. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J Rheumatol 2008;35:1271-6.
2. Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 2008;67:84-90.
3. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007;30:945-50.